Pancreatic Neuroendocrine Tumors
625 articles
Pancreatic Cancer Patients Have a Role in Treatment Choices
Pancreatic Cancer UK’s Peter De Rosa explains how patient-reported outcome measures can help direct treatment choices and supportive care.
Using AI to Create a Better Test to Predict Pancreatic Cancer Progression
Dr. Dan Theodorescu is using AI to isolate more effective biomarkers than the CA 19-9 test to track pancreatic cancer progression.
Common Anti-Anxiety Medications May Affect Outcomes
Many pancreatic cancer patients take anti-anxiety medications. But what you take may affect how your treatment works, says Dr. Michael Feigin.
Representing Genetic and Clinical Diversity in Pancreatic Cancer
Dr. Kentaro Sudo explores the possible causes for different responses to drugs among ethnic groups, pointing to the need for clinical diversity in trials.
Early Study Shows Exercise Alone Can Reduce Inflammation
Dr. Zobeida Cruz-Monserrate is studying how exercise can reduce inflammation, and how that impacts pancreatic cancer.
Finding More Targets for Pancreatic Cancer Treatment
Dr. Noelle LoConte discusses a clinical trial for cancer patients, including pancreatic cancer patients, that have an NRG1 gene fusion.
Periodontal Disease and Pancreatic Cancer?
Did you know that periodontal disease may predict pancreatic cancer? Researchers are finding a link between unhealthy gums and the deadly cancer.
CAR T Cell Trial Targets Mesothelin
In an immunotherapy clinical trial, Dr. Mark O’Hara is using CAR T cells to attack mesothelin-expressing tumor cells in pancreatic cancer.
Laboratory Study Shows Keto Diet May Enhance Chemotherapy
Dr. Joshua Rabinowitz’s initial study has found that a Keto diet may enhance the effects of chemotherapy and treatment for pancreatic cancer.
AI Platform Reveals Hidden Biology of Tumor Formation
Dr. Laura Wood and colleagues are developing an artificial intelligence (AI) platform to identify tumors as they are forming.
Pancreatic Microbiome May Hold the Key To Better Treatment
Dr. Deirdre Cohen’s research into the pancreatic microbiome has found that gut bacteria may directly influence the effectiveness of immunotherapy.